PEN PENUMBRA INC
2026Q1 · CUSIP 70975L107 · Sector: Healthcare & Biotech
Lit · Institutions accelerating in
Holders
478
Δ holders QoQ
+43
Breadth percentile
Top 6%
Whale holders
207
Δ whales
+7
Inst. holding value
$65.9B
New positions
131
Closed positions
88
Price momentum (1Q)
-4.2%
Put / Call
7/7
Breadth history (34 quarters)
Past Lit Events & Aftermath 14 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2026Q1 | Top 6% | — | — |
| 2025Q2 | Top 9% | +9.7% | +33.7% |
| 2025Q1 | Top 2% | -10.1% | -1.1% |
| 2024Q4 | Top 12% | +3.8% | -6.6% |
| 2023Q2 | Top 2% | -15.8% | +6.9% |
| 2023Q1 | Top 9% | -18.7% | -27.4% |
| 2022Q4 | Top 14% | +17.7% | -6.2% |
| 2022Q3 | Top 15% | +33.9% | +60.6% |
Options Sentiment
Put holders
7
QoQ: +3
Call holders
7
QoQ: +2
See methodology →
Fundamentals
PE (TTM)
73.3
EPS (TTM)
$4.34
EPS YoY
+301.9%
Revenue (TTM)
$1.5B
Revenue YoY
+17.3%
Net margin
11.8%
ROE
11.6%
Debt ratio
22.4%
FCF (TTM)
$213M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.